Skip to main content
. 2020 Mar 27;15(3):e0230878. doi: 10.1371/journal.pone.0230878

Fig 3. Resistance of HIV-1 to antiretroviral drugs.

Fig 3

The evaluated samples were collected in the period between 2008 and 2017 in the state of Maranhão, Brazil. In the period 2008–2012, data of 2010 were excluded. ATV/r: Atazavanir/ritonavir, DRV/r: Darunavir/ritonavir, LPV/r: Lopinavir/ritonavir, ABC: Abacavir, AZT: Zidovudine, FTC: Emtricitabine, 3TC: Lamivudine, TDF: Tenofovir, EFV: Efavirenz, ETR: Etravirine, NVP: Nevirapine, RPV: Rilpivirine.